GlassScriptPhysician profile
George S Sehl
NPI 1194806448
$4,362.45
in general payments reported to CMS, 2019-2025
18 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $125 · 2021: $393 · 2022: $2,864 · 2023: $62.93 · 2024: $251 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,154.96 | 2019-2024 | Viaflow, Ortholoc 2 Lapifuse |
| Organogenesis INC. | $329.98 | 2019-2022 | |
| Surgenex LLC | $149.75 | 2025 | Pellograft, Surmatrix, Surgraft |
| Horizon Therapeutics Plc | $120.75 | 2019-2023 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $89.25 | 2021 | |
| Depuy Synthes Sales INC. | $87.39 | 2021-2024 | Motoband, Crosstie, Na |
| Kerecis Limited | $70.19 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Zimmer Biomet Holdings, INC. | $58.33 | 2019-2024 | |
| Smith+Nephew, INC. | $56.71 | 2021-2022 | |
| Treace Medical Concepts, INC. | $48.68 | 2024 | |
| Nevro Corp. | $45.29 | 2024 | Senza |
| Kowa Pharmaceuticals America, INC. | $35.81 | 2022 | |
| Alfasigma USA, INC. | $27.86 | 2020-2022 | |
| Djo, LLC | $21.78 | 2023 | Cmf |
| Amgen INC. | $20.06 | 2024 | Krystexxa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $18.79 | 2024 | Nuzyra |
| Acera Surgical, INC. | $16.07 | 2020 | |
| Arthrosurface Incorporated | $10.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Sehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.